Inventor · disambiguated record
Jeffrey Michael Axten
Also filed as: AXTEN JEFFREY M · AXTEN JEFFREY MICHAEL
16 granted patents·9 pending applications·160 citations·filing 1999–2022
92Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD7GLAXO GROUP LTD5AXTEN JEFFREY MICHAEL4GLAXOSMITHKLINE LLC3AXTEN JEFFREY M2
Top patents by PatentIndex Score
25 records- 0188US7648984B2Antibacterial agentsGLAXO GROUP LTD·Filed 2005·Granted Jan 19, 2010·13 cites·10 claims
- 0286US8697685B2Chemical compoundsAXTEN JEFFREY MICHAEL·Filed 2009·Granted Apr 15, 2014·25 cites·8 claims
- 0386US7232832B2Antibacterial agentsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jun 19, 2007·18 cites·11 claims
- 0484US11547704B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 10, 2023·1 cites·4 claims
- 0584US6025502AEnantopselective synthesis of methyl phenidateUNIV PENNSYLVANIA·Filed 1999·Granted Feb 15, 2000·63 cites·17 claims
- 0681US7498326B2CompoundsGLAXO GROUP LTD·Filed 2003·Granted Mar 3, 2009·12 cites·16 claims
- 0779US7884098B2Anthranilamide inhibitors of aurora kinaseGLAXOSMITHKLINE LLC·Filed 2008·Granted Feb 8, 2011·3 cites·3 claims
- 0878US8598156B2Chemical compoundsAXTEN JEFFREY MICHAEL·Filed 2011·Granted Dec 3, 2013·7 cites·17 claims
- 0974US7622481B2Antibacterial compoundsGLAXO GROUP LTD·Filed 2003·Granted Nov 24, 2009·7 cites·24 claims
- 1074US2023165848A1Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2022·Application pending·0 cites
- 1172US10851053B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Dec 1, 2020·1 cites·4 claims
- 1272US7618959B2Antibacterial agentsGLAXO GROUP LTD·Filed 2003·Granted Nov 17, 2009·5 cites·23 claims
- 1371US7495102B2Azaindole inhibitors of aurora kinasesSMITHKLINE BEECHAM CORP·Filed 2007·Granted Feb 24, 2009·1 cites·12 claims
- 1468US8383635B2Chemical compoundsGLAXOSMITHKLINE LLC·Filed 2009·Granted Feb 26, 2013·1 cites·9 claims
- 1564US7491714B2Quinolines and nitrogenated derivatives thereof and their use as antibacterial agentsGLAXO GROUP LTD·Filed 2003·Granted Feb 17, 2009·3 cites·23 claims
- 1664US2010081650A1Antimicrobial CompoundsAXTEN JEFFREY MICHAEL·Filed 2009·Application pending·0 cites
- 1752US2019298705A1Chemical CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 1848US2021093619A1Chemical Compounds as ATF-4 Pathway InhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 1945US11773078B2Furin inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Oct 3, 2023·0 cites·22 claims
- 2044US2019241573A1Isoquinoline derivatives as perk inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 2142US2005272936A1Imidazolium cxcr3 inhibitorsAXTEN JEFFREY M·Filed 2003·Application pending·0 cites
- 2242US2006041123A1Antibacterial agentsAXTEN JEFFREY M·Filed 2003·Application pending·0 cites
- 2340US7982053B2Peptide deformylase inhibitorsGLAXOSMITHKLINE LLC·Filed 2006·Granted Jul 19, 2011·0 cites·8 claims
- 2436US2018237441A1Chemical CompoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Application pending·0 cites
- 2534US2012077828A1Chemical compoundsAXTEN JEFFREY MICHAEL·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey Michael Axten files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →